Enrollment open • Metastases
|
PD-L1 (Programmed death ligand 1) • BRAF (B-raf proto-oncogene) • PD-1 (Programmed cell death 1)
|
PD-L1 expression • BRAF mutation • PD-L1 negative
|
PD-L1 IHC 22C3 pharmDx
|
Keytruda (pembrolizumab) • threitolceramide 6 liposomal (PORT-2)